Organon Financial Statements (OGN)
|
|
|
|
Report date
|
|
|
02.05.2025 |
06.08.2025 |
10.11.2025 |
24.02.2026 |
04.05.2026 |
|
04.05.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
1 513 |
1 594 |
1 602 |
1 507 |
1 460 |
|
6 163 |
|
Operating Income, bln rub |
|
|
325.0 |
326.0 |
358.0 |
235.0 |
266.0 |
|
1 185 |
|
EBITDA, bln rub |
? |
|
325.0 |
449.0 |
460.0 |
65.0 |
351.0 |
|
1 325 |
|
Net profit, bln rub |
? |
|
87.0 |
145.0 |
160.0 |
-205.0 |
146.0 |
|
246.0 |
|
|
OCF, bln rub |
? |
|
75.0 |
220.0 |
264.0 |
141.0 |
225.0 |
|
850.0 |
|
CAPEX, bln rub |
? |
|
97.0 |
39.0 |
115.0 |
45.0 |
37.0 |
|
236.0 |
|
FCF, bln rub |
? |
|
-22.0 |
181.0 |
149.0 |
96.0 |
188.0 |
|
614.0 |
|
Dividend payout, bln rub
|
|
|
71.0 |
10.00 |
3.00 |
4.00 |
5.00 |
|
22.0 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
81.6% |
6.90% |
1.88% |
0.00% |
3.42% |
|
8.94% |
|
|
OPEX, bln rub |
|
|
516.0 |
548.0 |
499.0 |
524.0 |
517.0 |
|
2 088 |
|
Cost of production, bln rub |
|
|
672.0 |
720.0 |
745.0 |
748.0 |
677.0 |
|
2 890 |
|
R&D, bln rub |
|
|
96.0 |
95.0 |
84.0 |
91.0 |
93.0 |
|
363.0 |
|
Interest expenses, bln rub |
|
|
124.0 |
132.0 |
128.0 |
121.0 |
111.0 |
|
492.0 |
|
|
Assets, bln rub |
|
|
13 156 |
13 500 |
13 552 |
12 867 |
12 996 |
|
12 996 |
|
Net Assets, bln rub |
? |
|
542.0 |
733.0 |
906.0 |
752.0 |
903.0 |
|
903.0 |
|
Debt, bln rub |
|
|
8 956 |
8 896 |
8 828 |
8 800 |
8 569 |
|
8 569 |
|
Cash, bln rub |
|
|
547.0 |
599.0 |
672.0 |
574.0 |
1 116 |
|
1 116 |
|
Net debt, bln rub |
|
|
8 409 |
8 297 |
8 156 |
8 226 |
7 453 |
|
7 453 |
|
|
Ordinary share price, rub |
|
|
14.9 |
9.68 |
10.7 |
7.17 |
5.99 |
|
13.3 |
|
Number of ordinary shares, mln |
|
|
257.9 |
259.9 |
260.0 |
260.2 |
260.4 |
|
260.4 |
|
|
Market cap, bln rub |
|
|
3 840 |
2 516 |
2 777 |
1 865 |
1 560 |
|
3 473 |
|
EV, bln rub |
? |
|
12 249 |
10 813 |
10 933 |
10 091 |
9 013 |
|
10 926 |
|
Book value, bln rub |
|
|
-5 555 |
-5 309 |
-5 114 |
-4 531 |
-4 349 |
|
-4 349 |
|
|
EPS, rub |
? |
|
0.34 |
0.56 |
0.62 |
-0.79 |
0.56 |
|
0.94 |
|
FCF/share, rub |
|
|
-0.09 |
0.70 |
0.57 |
0.37 |
0.72 |
|
2.36 |
|
BV/share, rub |
|
|
-21.5 |
-20.4 |
-19.7 |
-17.4 |
-16.7 |
|
-16.7 |
|
|
EBITDA margin, % |
? |
|
21.5% |
28.2% |
28.7% |
4.31% |
24.0% |
|
21.5% |
|
Net margin, % |
? |
|
5.75% |
9.10% |
9.99% |
-13.6% |
10.00% |
|
3.99% |
|
FCF yield, % |
? |
|
15.7% |
19.2% |
20.4% |
21.7% |
39.4% |
|
17.7% |
|
ROE, % |
? |
|
138.4% |
95.5% |
55.3% |
24.9% |
27.2% |
|
27.2% |
|
ROA, % |
? |
|
5.70% |
5.19% |
3.70% |
1.45% |
1.89% |
|
1.89% |
|
|
P/E |
? |
|
5.12 |
3.59 |
5.54 |
9.98 |
6.34 |
|
14.1 |
|
P/FCF |
|
|
6.39 |
5.22 |
4.91 |
4.62 |
2.54 |
|
5.66 |
|
P/S |
? |
|
0.61 |
0.40 |
0.44 |
0.30 |
0.25 |
|
0.56 |
|
P/BV |
? |
|
-0.69 |
-0.47 |
-0.54 |
-0.41 |
-0.36 |
|
-0.80 |
|
EV/EBITDA |
? |
|
8.17 |
7.13 |
6.94 |
7.77 |
6.80 |
|
8.25 |
|
Debt/EBITDA |
|
|
5.61 |
5.47 |
5.18 |
6.33 |
5.62 |
|
5.62 |
|
|
R&D/CAPEX, % |
|
|
99.0% |
243.6% |
73.0% |
202.2% |
251.4% |
|
153.8% |
|
|
CAPEX/Revenue, % |
|
|
6.41% |
2.45% |
7.18% |
2.99% |
2.53% |
|
3.83% |
|
| Organon shareholders |
